from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0867c/rpfA

LFCtreatmentdescriptionclass of inhibitor

-0.249

Amikacinug/mL Amikacintranslation

-0.342

Cap5-10ug/mL Capreomycintranslation

-0.631

Rox10-50 ug/mL Roxithromycintranslation

0.525

SM2-5 ug/mL Streptomycintranslation

-0.982

Tet5-10 ug/mL Tetracyclinetranslation

0.473

Rif0.2-5ug/mL Rifampicintranscription

0.653

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.813

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.454

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.596

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.381

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.014

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.740

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.804

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.081

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.212

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.024

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.098

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.258

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.373

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.698

KCN5-20 ug/mL Potassium cyaniderespiration

-0.714

NaN30.2-2 mM Sodium aziderespiration

0.503

Nigericin50 uM Nigericinrespiration

-0.313

TRC10-150 ug/mL Triclosanrespiration

-1.948

TRZ10-25 ug/mL Thioridazinerespiration

-0.090

Valinomycin0.5-10 uM Valinomycinrespiration

0.001

ZnSO42 mM ZnSO4respiration

0.197

menadione6-10 ug/mL Menadionerespiration

0.897

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.867

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.165

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.823

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.618

NRP_1Non-replicating persistence stage 1dosRassociated

0.597

Amp0.2mg/mL AmpicillincellWall

0.540

Cephalexin20-100 ug/mL CephalexincellWall

0.920

Cerulenin0.32-5 ug/mL CerulenincellWall

0.755

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.247

EMB10-20 ug/mL EthambutolcellWall

-0.395

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.112

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.085

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.615

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.411

BZA0.12 mg/mL BenzamidearomaticAmides

0.017

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.098

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.524

H2O24 mM hydrogen peroxideDNAdamaging

0.221

Levo10 ug/mL LevofloxacinDNAdamaging

0.686

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.785

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.545

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.905

UVUV-irradiationDNAdamaging

-0.832

ARP41-4 ug/mL Antitubercular compound ARP4?

0.819

Antimycin12.5-50 ug/mL Antimycin A?

0.260

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.375

PA_110-50 ug/mL Antitubercular compound PA-1?

1.293

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.978

PA8240.2-2 ug/mL PA-824?

-0.657

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.205

Verapamil50 uM Verapamil?

0.614

mercaptoethanol2 mM 2-Mercaptoethanol?

0.834

methoxatin10-20 ug/mL Methoxatin?